Sljedeći

Auto Play

Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma

3 Pogledi • 07/18/23
Udio
Ugraditi
administrator
administrator
Pretplatnici
0

Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in unresectable and metastatic soft tissue sarcoma.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/

Prikaži više
0 Komentari sort Poredaj po
Komentari na Facebooku

Sljedeći

Auto Play